A leading company in hospital robotics that assists surgeons in complex operations, which can even be performed remotely from other countries.
A massive expansion of these systems is expected, especially in emerging markets.
Weakness in the medical sector is pushing the stock price to break below the $400 level, potentially heading toward the $370 area, where the weekly SMA200 (blue line) passes — a level that could represent an excellent entry point.
A massive expansion of these systems is expected, especially in emerging markets.
Weakness in the medical sector is pushing the stock price to break below the $400 level, potentially heading toward the $370 area, where the weekly SMA200 (blue line) passes — a level that could represent an excellent entry point.
Note
Entry point very nearTrade active
Price reached the entry point at the bottom of the green channelNote
Support broken, retest will probably follow Trade closed: stop reached
Note
Double top confirmed
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.